Abstract
There is a growing interest in assessing quality of life in patients with oesophageal cancer because it provides detailed information of the patients’ perception of the benefits or harms of treatment. Yet few studies have prospectively measured quality of life using validated appropriate instruments. There are now several questionnaires for patients with cancer, although these are not sufficiently sensitive to small but clinically important changes in quality of life. It is therefore recommended that a disease-specific module is used in conjunction with generic measures. The European Organisation into Research and Treatment of Cancer (EORTC) QLQ-OES24 is currently completing an international validation study. It is used with the EORTC QLQ-C30 core instrument and is designed for patients undergoing potentially curative treatment or palliation of malignant dysphagia.
Studies that have assessed quality of life after oesophagectomy have generally found that survivors do regain their former health. Little is known about the effect of neoadjuvant chemoradiation on patients’ quality of life. Following endoscopic palliation of dysphagia, quality of life can be maintained and improvement of swallowing is seen. A validated appropriate assessment of quality of life should be included in future palliative trials and in studies of new treatments which may marginally influence survival but cause significant side effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Earlam R, Cunha-Melo JR (1980) Oesophageal squamous cell carcinoma: 1. A critical review of surgery. Br J Surg 67: 381–390
Watson A (1982) A study of the quality and duration of survival following resection, endoscopic intubation and surgical intubation in oesophageal carcinoma. Br J Surg 69: 585–588
van Knippenberg FCE, Out JJ, Tilanus HW, Mud HJ, Hop WCJ, Verhage F (1992) Quality of life in patients with resected oesophageal cancer. Soc Sci Med 35: 139–145
Blazeby JM, Williams MH, Brookes ST, Alderson D, Farndon JR (1995) Quality of life measurement in patients with oesophageal cancer. Gut 37: 505–508
Barr H, Krasner N, Raouf A, Walker RJ (1990) Prospective randomised trial of laser therapy only and laser therapy followed by endoscopic intubation for the palliation of malignant dysphagia. Gut 31: 252–258
Loizou LA, Rampton D, Atkinson M, Robertson C, Bown SG (1992) A prospective assessment of quality of life after endoscopic intubation and laser therapy for malignant dysphagia. Cancer 70: 386–391
Schipper H, Clinch J, Powell V (1990) Definitions and conceptual issues. In: Spilker B (ed) Quality of life assessments in clinical trials. Raven, New York, pp 11–24
Blazeby JM, Williams MH, Alderson D, Farndon JR (1995) Observer variation in assessment of quality of life in patients with oesophageal cancer. Br J Surg 82: 1200–1203
Bremer BA, McCauley CR (1986) Quality of life measures: hospital interview versus home questionnaire. Health Psychol 5: 171–177
Aaronson NK, Cull A, Kaasa S, Sprangers MAG (1994) The EORTC modular approach to quality of life assessment in oncology. Int J Ment Health 23: 75–96
Stoller JL, Samer KJ, Toppin DI, Flores AD (1977) Carcinoma of the oesophagus. A new proposal for the evaluation of treatment. Can J Surg 20: 454–459
McCaughan JS Jr, Williams TE Jr, Bethel BH (1985) Palliation of oesophageal malignancy with photodynamic therapy. Ann Thorac Surg 40: 113–120
Reed CE, Marsh WH, Carlson LS, Seymore CH, Kratz JM (1991) Prospective, randomised trial of palliative treatment for unresectable cancer of the oesophagus. Ann Thor-ac Surg 51: 552–556
Karnofsky DA, Burchenal JH (1949) The clinical evaluation of chemotherapeutic agents in cancer. In: Macleod CM (ed) Experimental cancer therapy. Columbia University Press, New York, pp 191–205
McCaughan JS, Nims TA, Guy JT, Hicks W], Williams TE, Laufman LR (1989) Photodynamic therapy for oesophageal tumours. Arch Surg 124: 74–80
Mahoney JL, Condon RE (1987) Adenocarcinoma of the oesophagus. Ann Surg 205: 557–562
Albertsson M, Ewers SB, Widmark H, Hambraeus G, Lillo-Gil R, Ranstam J (1989) Evaluation of the palliative effect of radiotherapy for oesophageal carcinoma. Acta On-col 28: 267–270
Flores AD (1989) Cancer of the oesophagus and cardia: overview of radiotherapy. Can J Surg 32: 404–409
Flores AD, Nelems B, Evans K, Hay JH, Stoller J, Jackson SM (1989) Impact of new radiotherapy modalities on the surgical management of cancer of the oesophagus and cardia. Int J Radiat Oncol Biol Phys 17: 937–944
O’Rourke IC, McNeil RJ, Walker PJ, Bull CA (1992) Objective evaluation of the quality of palliation in patients with oesophageal cancer comparing surgery, radiotherapy and intubation. Aust NZ J Surg 62: 922–930
Herskovic A, Martz K, Al-Sarraf M, Leichman LP, Brindle J, Vaitkevicius V et al (1992) Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus. N Engl J Med 326: 1593–1598
Knyrim K, Wagner HJ, Bethge N, Keymling M, Vakil N (1993) A controlled trial of an expansile metal stent for palliation of oesophageal obstruction due to inoperable cancer. N Engl J Med 329: 1302–1307
Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y et al (1995) Mortality and morbidity rates, postoperative course, quality of life, and prognosis after extended radical lymphadenectomy for oesophageal cancer. Ann Surg 222: 654–662
Zubrod CG, Schneiderman M, Frei E, Brindley C, Gold GL, Shnider B et al (1960) Appraisal of methods for the study of chemotherapy of cancer in man: comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11: 7–33
Mellow MH, Pinkas H (1985) Endoscopic laser therapy for malignancies affecting the oesophagus and gastroesophageal junction. Arch Intern Med 145: 1443–1446
Rutgeerts P, Vantrappen G, Broeckaert L, Muls M, Geboes K, Coremans G et al (1988) Palliative Nd:YAG laser therapy for cancer of the oesophagus and gastroesophageal junction: impact on the quality of remaining life. Gastrointest Endosc 34: 87–89
Highley MS, Parnis FX, Trotter GA, Houston SJ, Penson RT, Harper PG et al (1994) Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and oesophageal adenocarcinoma. Br J Surg 81: 1763–1765
World Health Organisation (1979) World Health Organisation handbook for reporting results of cancer treatment. WHO, Geneva
Chavy AL, Rougier M, Pieddeloup SA, Kac J, Laplanche AC, Elias DM et al (1986) Oesophageal prosthesis for neoplastic stenosis. A prognostic study of 77 cases. Cancer 57: 1426–1431
Sugimachi K, Maekawa S, Koga Y, Ueo H, Inokuchi K (1986) The quality of life is sustained after operation for carcinoma of the oesophagus. Surg Gynecol Obstet 162: 544–547
Baba M, Aikou T, Natsugoe S, Kusano C, Shimada M, Kimura S et al (1997) Appraisal of ten-year survival following oesophagectomy for carcinoma of the oeosphagus with emphasis on quality of life. World J Surg 21: 282–286
Baba M, Aikou T, Natsugoe S, Kusano C, Shimada M, Nakano S et al (1998) Quality of life following oesophagectomy with three field lymphadenectomy for carcinoma, focusing on its relationship to vocal cord palsy. Dis Oesop 11: 28–34
Priestman TJ, Baum M (1976) Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet i: 899–900
Barr H, Krasner N (1991) Prospective quality-of-life analysis after palliative photoablation for the treatment of malignant dysphagia. Cancer 68: 1660–1664
Loizou LA, Grigg D, Atkinson M, Robertson C, Sown SG (1991) A prospective comparison of laser therapy and intubation in endoscopic palliation of malignant dysphagia. Gastroenterology 100: 1303–1310
Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R et al (1981) Measuring the quality of life of cancer patients. A concise QL-index for use by physicians. J Chron Dis 34: 585–597
Zieren HU, Jacobi CA, Zieren J, Muller JM (1996) Quality of life following resection of oesophageal carcinoma. Br J Surg 83: 1772–1775
de Haes JCJM, van Knippenberg FCE, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62: 1034–1038
Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A et al (1993) The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol 11: 570–579
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376
Sprangers MAG, Cull A, Bjordal K, Groenvold M, Aaronson NK (1993) The European Organisation for Research and Treatment of Cancer approach to quality of life assessment: guidelines for developing questionnaire modules. Qual Life Res 2: 287–295
Ringdal GI, Ringdal K (1993) Testing the EORTC quality of life questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 2: 129–140
Blazeby JM, Alderson D, Winstone K, Steyn R, Hammerlid E, Arraras J et al (1996) Development of a EORTC questionnaire module to be used in quality of life assessment for patients with oesophageal cancer. Eur J Cancer 32: 1912–1917
Blazeby JM, Alderson D, Farndon JR, Conroy T, Arraras J, Hammerlid E et al (1997) An international field study to test the EORTC QLQ-C30 and oesophageal cancer module (EORTC QLQ-OES24) among patients with oesophageal cancer. Protocol no 15961/ 40973
Ware JE, Snow KK, Kosinski M, Gandek B (1993) SF-36 Health survey manual and interpretation guide. New England Medical Centre, Boston
Jenkinson C, Coulter A, Wright L Short form 36(SF36) health survey questionnaire: normative data for adults of working age. Br Med J 306: 1437–1444
Garratt AM, Ruta DA, Abdalla MI, Buckingham JK, Russell IT (1993) The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS? Br Med J 306: 1440–1444
McLarty AJ, Deschamps C, Trastek VF, Allen MS, Pairolero PC, Harmsen WS (1997) Oesophageal resection for cancer of the oesophagus: long-term function and quality of life. Ann Thorac Surg 63: 1568–1572
Visick AH (1948) A study of the failures after gastrectomy. Ann R Coll Surg Engl 3: 266–284
Gasparri G, Casalegno PA, Camandona M, Dei Poli M, Salizzoni M, Ferrarotti G et al (1987) Endoscopic insertion of 248 prostheses in inoperable carcinoma of the oesophagus and cardia: short-term and long-term results. Gastrointest Endosc 33: 354–356
Barbier PA, Luder PJ, Schupfer G, Becker CD, Wagner HE (1988) Quality of life and patterns of recurrence following transhiatal oesophagectomy for cancer: results of a prospective follow-up in 50 patients. World J Surg 12: 270–276
Fuchs KH, Freys SM, Schaube H, Eckstein AK, Selch A, Hamelmann H (1991) Randomised comparison of endoscopic palliation of malignant oesophageal stenoses. Surg Endos 5: 63–67
Roder JD, Herschbach P, Sellschopp A, Siewert JR (1991) Quality-of-life assessment following oesophagectomy. Theor Surg 6: 206–210
Kuwano H, Ikebe M, Baba K, Kitamura K, Toh Y, Matsuda H et al (1993) Operative procedures of reconstruction after resection of oesophageal cancer and the post operative quality of life. World J Surg 17: 773–776
Bluett MK, Sawyers JL, Healy D (1987) Oesophageal carcinoma. Improved quality of survival with resection. Am Surg 53: 126–132
Blazeby JM (1998) Quality of life in patients with oesophageal cancer. MD thesis, Bristol University
O’Hanlon D, Harkin M, Daya K, Sergeant T, Hayes N, Griffin SM (1995) Quality of life assessment in patients undergoing treatment for oesophageal carcinoma. Br J Surg 82: 1682–1685
Sawant D, Moghissi K (1994) Management of unresectable oesophageal cancer: a review of 537 patients. Eur J Cardiothorac Surg 8: 113–117
Bamias A, Hill ME, Cunningham D, Norman AR, Ahmed FY, Webb A et al (1996) Epirubicin, cisplatin, and protracted venous infusion of 5-fluorouracil for oesophagogastric adenocarcinoma. Cancer 77: 1978–1985
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Blazeby, J.M., Alderson, D., Farndon, J.R. (2000). Quality of Life in Patients with Oesophageal Cancer. In: Lange, J., Siewert, J.R. (eds) Esophageal Carcinoma. Recent Results in Cancer Research, vol 155. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59600-1_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-59600-1_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-64044-5
Online ISBN: 978-3-642-59600-1
eBook Packages: Springer Book Archive